Many community oncology practices become involved in pharmaceutical industry-sponsored clinical trials for two good reasons:

to supplement their menu of clinical research projects and to expand treatment options for their patients. Expectations of the site’s investigators are that the sponsor will cover the costs of performing the research. 

Visit http://www.praxisaustralia.com.au/media/W1siZiIsIjIwMTcvMDkvMTEvMXVnNzQ2ZmVpZl9EZXZlbG9wbmdfU2l0ZS5wZGYiXV0 for the full article.